Overview
- Defense Secretary Pete Hegseth announced the program on Wednesday, July 15, 2026, and Pentagon spokesman Sean Parnell said mandatory annual tests take effect immediately for active and reserve troops aged 30 and older.
- The Pentagon frames the effort as a readiness and health measure to detect low testosterone and offer optional replacement therapy to affected service members.
- Officials have not specified clinical details such as diagnostic thresholds, which medical conditions the program targets, or whether women will be included in screening or offered hormone care.
- Medical guidelines and many experts warn that routine population screening for testosterone is not standard practice because levels vary by time of day and diagnosis generally requires symptoms plus confirmatory tests.
- The policy follows a 2022 Navy SEAL recruit case that exposed non‑medical hormone use and tracks with recent FDA and White House moves to ease access to testosterone, raising questions about fertility risks, cardiovascular concerns, and equity in care.